What it is
Chronic subdural haematoma, a slow bleed over the brain, often returns after surgery. The OTEMACS trial randomly assigned adults at six hospitals in France to standard treatment plus early middle-meningeal-artery embolisation or standard treatment alone. In the main analysis the composite outcome of reoperation, large residual bleed or death at 90 days occurred in 32.7% of the embolisation group versus 49.0% of controls, and reoperation specifically in 7.3% versus 18.3%.
Why it matters
Chronic subdural haematoma is increasingly common in older people, and repeat surgery carries real risk, so a procedure that keeps the bleed from coming back would matter. Earlier trials of this embolisation have been mixed, which is why a clean randomised comparison was needed.
Underlined numbers link to their source. Every metric and quoted figure is listed under Sources and data below.
Filed underNeurosurgical Procedures and Complications, Migraine and Headache Studies, Spinal Hematomas and Complications